Bank of America Securities analyst Allen Lutz maintained a Sell rating on Doximity (DOCS – Research Report) on January 26 and set a price target of $27.00. The company’s shares closed last Friday at $34.95.
According to TipRanks, Lutz is ranked #4463 out of 8269 analysts.
Currently, the analyst consensus on Doximity is a Moderate Buy with an average price target of $39.22.
See today’s best-performing stocks on TipRanks >>
Based on Doximity’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $102.19 million and a net profit of $26.3 million. In comparison, last year the company earned a revenue of $79.35 million and had a net profit of $36.09 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Read More on DOCS: